Mofezolac Inhibitor

Name: Mofezolac Inhibitor; MyBioSource
Brand: MyBioSource
SKU: MBS5751860
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5751860

Mofezolac (formerly known as Disopain or N-22) is a highly selective COX-1 (cyclooxygenase-1) inhibitor with COXs selectivity index >6000 More details

Please Inquire

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

Mofezolac, Inhibitor

Full Product Name

Mofezolac

Form/Format

Powder

Purity/Purification

98.00%

Preparation and Storage

Store at -20 degree C for 3 years powder; -80 degree C for 2 years in solvent
For obtaining a higher solubility, please warm the tube at 37 degree C and shake it in the ultrasonic bath for a while. Stock solution can be stored below -20 degree C for several month.

Molecular Weight

339.35

Formula

C19H17NO5

CAS

78967-07-4

Smiles

COc1ccc(cc1)-c1noc(CC(O)=O)c1-c1ccc(OC)cc1

Solubility

DMSO: 10mM
Water: Insoluble
Ethanol: Insoluble
(<1mg/ml refers to the product slightly soluble or insoluble)

Product Categories/Family for Mofezolac, inhibitor

Home; Immunology/Inflammation; COX

Product References and Citations for Mofezolac, inhibitor

1. Calvello R, et al.Highly Selective Cyclooxygenase-1 Inhibitors P6 and Mofezolac Counteract Inflammatory State both In Vitro and In Vivo Models of Neuroinflammation.Front Neurol. 2017 Jun 9;8:251

Other Notes

Small volumes of Mofezolac, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Mofezolac purchase

MBS5751860 is an inhibitor targeting Mofezolac.